Assessing the risk of breast cancer.

被引:208
作者
Armstrong, K
Eisen, A
Weber, B
机构
[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA
[4] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
关键词
D O I
10.1056/NEJM200002243420807
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:564 / 571
页数:8
相关论文
共 72 条
[1]  
ANDERSON DE, 1985, CANCER, V56, P383, DOI 10.1002/1097-0142(19850715)56:2<383::AID-CNCR2820560230>3.0.CO
[2]  
2-0
[3]  
[Anonymous], 1999, SEER CANC STAT REV 1
[4]   VALIDATION OF A BREAST-CANCER RISK ASSESSMENT MODEL IN WOMEN WITH A POSITIVE FAMILY HISTORY [J].
BONDY, ML ;
LUSTBADER, ED ;
HALABI, S ;
ROSS, E ;
VOGEL, VG .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (08) :620-625
[5]   ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK-FACTORS USING CASE-CONTROL DATA [J].
BRUZZI, P ;
GREEN, SB ;
BYAR, DP ;
BRINTON, LA ;
SCHAIRER, C .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 122 (05) :904-913
[6]   American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: Tamoxifen and raloxifene [J].
Chlebowski, RT ;
Collyar, DE ;
Somerfield, MR ;
Pfister, DG .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1939-1955
[7]  
CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO
[8]  
2-5
[9]   Patient-specific decisions about hormone replacement therapy in postmenopausal women [J].
Col, NF ;
Eckman, MH ;
Karas, RH ;
Pauker, SG ;
Goldberg, RJ ;
Ross, EM ;
Orr, RK ;
Wong, JB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (14) :1140-1147
[10]   Risk factors for breast cancer according to family history of breast cancer [J].
Colditz, GA ;
Rosner, BA ;
Speizer, FE .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (06) :365-371